✦ LIBER ✦

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials

✍ Scribed by Janaina Brollo; Giuseppe Curigliano; Davide Disalvatore; Bianca Fontana Marrone; Carmen Criscitiello; Vincenzo Bagnardi; Maximiliano Cassilha Kneubil; Luca Fumagalli; Marzia Locatelli; Silvia Manunta; Aron Goldhirsch

Book ID: 119224503
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 293 KB
Volume: 39
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2012.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant/neoadjuvant trastuzumab therapy

Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review

✍ Yolanda Madarnas; Maureen Trudeau; Jacob A. Franek; David McCready; Kathleen I. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 246 KB

2-year follow-up of trastuzumab after ad

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

✍ Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyerei 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB

A Meta-Analysis of Randomized Controlled

A Meta-Analysis of Randomized Controlled Trials Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Alone in HER-2-Positive Advanced Breast Cancer

✍ Cun Liao; Fang Yin; Ping Huang; Yunfei Cao; Feng Gao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Trastuzumab combined to neoadjuvant chem

Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis

✍ Antonis Valachis; Davide Mauri; Nikolaos P. Polyzos; Grigoris Chlouverakis; Dimi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Management and Outcome of HER2-Positive

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

✍ Carlo Palmieri; Deep Shah; Jonathan Krell; Ondrej Gojis; Katy Hogben; Pippa Ridd 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Neoadjuvant chemotherapy with trastuzuma

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

✍ Luca Gianni; Wolfgang Eiermann; Vladimir Semiglazov; Alexey Manikhas; Ana Lluch; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 124 KB